Evaluation of early chemotherapy response by combining static- and dynamic [18F]FDG-PET with diffusion-weighted MRI in subcutaneous patient-derived endometrial cancer mouse models
Multimodal imaging is feasible for evaluation of early signs of treatment response in preclinical subcutaneous endometrial cancer models. The novel MR<sub>FDG</sub> dynamic PET imaging parameter seems most promising for detecting very early treatment response following chemotherapy.
Authors
- Jenny M. Lyngstad
- Camilla Krakstad (ORCID: https://orcid.org/0000-0002-0174-8139)
- Ingfrid S. Haldorsen (ORCID: https://orcid.org/0000-0001-9313-7564)
- Marta E. Hjelmeland
- Kristine E. Fasmer (ORCID: https://orcid.org/0000-0001-8773-7870)
- Hege F. Berg (ORCID: https://orcid.org/0000-0002-1712-6609)
- Heidi Espedal (ORCID: https://orcid.org/0000-0002-0190-8999)
Institutions
- Haukeland University Hospital (NO)
- National Imaging Facility (AU)
- University of Bergen (NO)
Publication Details
- Journal
- EJNMMI Research
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1186/s13550-025-01235-5
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- Trond Mohn stiftelse
- Universitetet i Bergen
- Norges Forskningsråd
- Haukeland Universitetssjukehus